Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Queensland Health
Dow
Moodys
AstraZeneca
McKinsey
Julphar

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Reparixin

« Back to Dashboard

US Patents for Reparixin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Reparixin ➤ Sign Up Use of (R)--ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs Dompe Pha.r.ma S.p.A. (L'Aquila, IT) ➤ Sign Up
Reparixin ➤ Sign Up 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them Dompe Pha.R.Ma S.p.A. (L'Aquila, IT) ➤ Sign Up
Reparixin ➤ Sign Up 2-arylpropionic acid derivatives and pharmaceutical compositions containing them DompePHA.R.MA S.p.A. (L'Aquila, IT) ➤ Sign Up
Reparixin ➤ Sign Up 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them ➤ Sign Up
Reparixin ➤ Sign Up 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them ➤ Sign Up
Reparixin ➤ Sign Up Breast tumor treatment with anti-CXCR1 compositions The Regents of The University of Michigan (Ann Arbor, MI) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Reparixin

Drugname Country Document Number Estimated Expiration Related US Patent
Reparixin Austria 304846 2021-02-02 ➤ Sign Up
Reparixin Australia 2002250869 2021-02-02 ➤ Sign Up
Reparixin Brazil 0206804 2021-02-02 ➤ Sign Up
Reparixin Canada 2432432 2021-02-02 ➤ Sign Up
Reparixin China 1561205 2021-02-02 ➤ Sign Up
Reparixin Czech Republic 20032095 2021-02-02 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Express Scripts
QuintilesIMS
Cantor Fitzgerald
Chubb
Julphar
Argus Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.